MDM2 promoter variation and age of diagnosis of acute lymphoblastic leukemia

This publication has 7 references indexed in Scilit:

• A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans
  Cell, 2004
• CYP1A1 variants and smoking‐related lung cancer in San Francisco bay area Latinos and African Americans
  International Journal of Cancer, 2004
• SEER update of incidence and trends in pediatric malignancies: Acute lymphoblastic leukemia
  Medical and Pediatric Oncology, 2002
• MDM2 AND p53 IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: Higher Expression in Childhood Leukemias with Poor Prognosis Compared to Long-Term Survivors
  Pediatric Hematology and Oncology, 2001
• 3'-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures
  Nucleic Acids Research, 2000
• Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.
  Journal of Clinical Oncology, 1997
• Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood
  Blood, 1993